Scarica l'app Stockscreener
4.72
1.51%
0.07
Precedente Chiudi:
$4.65
Aprire:
$4.64
Volume 24 ore:
92,351
Relative Volume:
0.40
Capitalizzazione di mercato:
$179.60M
Reddito:
-
Utile/perdita netta:
$-27.66M
Rapporto P/E:
-4.9684
EPS:
-0.95
Flusso di cassa netto:
$-24.36M
1 W Prestazione:
-15.56%
1M Prestazione:
-41.80%
6M Prestazione:
+92.65%
1 anno Prestazione:
+66.78%
Intervallo 1D:
$4.52
$4.72
Intervallo di 1 settimana:
$4.41
$5.89
Portata 52W:
$1.9875
$8.535
Genelux Corp Stock (GNLX) Company Profile
Nome
Genelux Corp
Settore
Industria
Telefono
805-267-9889
Indirizzo
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Confronta GNLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
4.72 | 176.94M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Lake Street | Buy |
| 2024-10-29 | Iniziato | Guggenheim | Buy |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2023-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2023-09-12 | Iniziato | Maxim Group | Buy |
| 2023-02-15 | Iniziato | The Benchmark Company | Speculative Buy |
Mostra tutto
Genelux Corp Borsa (GNLX) Ultime notizie
Genelux (NASDAQ:GNLX) Director Sells $50,000.00 in Stock - MarketBeat
Wall Street analysts’ outlook for Genelux Corp (GNLX) - Setenews
Global Retirement Partners LLC Acquires Shares of 228,676 Genelux Corporation $GNLX - MarketBeat
Genelux Corporation Executives to Participate in Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative
Genelux (NASDAQ: GNLX) sets Dec. 3 fireside chat at Piper Sandler 37th Conference - Stock Titan
Genelux Corp. Advances Phase 2 Study in NSCLC with Promising New Treatment - MSN
What risks investors should watch in Genelux Corporation stockForecast Cut & Daily Technical Forecast Reports - newser.com
Institutions along with retail investors who hold considerable shares inGenelux Corporation (NASDAQ:GNLX) come under pressure; lose 16% of holdings value - Yahoo Finance
Genelux initiated with a Buy at Titan Partners - MSN
Combining machine learning predictions for Genelux Corporation2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - newser.com
What momentum indicators show for Genelux Corporation stockSwing Trade & Expert Verified Stock Movement Alerts - newser.com
What valuation multiples suggest for Genelux Corporation stockWall Street Watch & Accurate Entry/Exit Alerts - newser.com
Will Genelux Corporation stock benefit from AI adoptionWeekly Trade Recap & High Return Trade Guides - newser.com
Can Genelux Corporation stock double in next 5 years2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Is Genelux Corporation stock attractive after correctionWatch List & Safe Entry Point Identification - newser.com
How hedge fund analytics apply to Genelux Corporation stock2025 Price Targets & Smart Swing Trading Techniques - newser.com
Will Genelux Corporation see short term momentumJuly 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
What MACD signals say about Genelux CorporationTrade Entry Report & Smart Money Movement Tracker - newser.com
Statistical indicators supporting Genelux Corporation’s strengthWeekly Trend Recap & Reliable Price Breakout Signals - newser.com
HC Wainwright Issues Positive Estimate for Genelux Earnings - Defense World
Will Genelux Corporation stock outperform Nasdaq index2025 Price Targets & Risk Controlled Daily Plans - newser.com
Genelux Corp. (GNLX) Receives a Buy from Lake Street - The Globe and Mail
Genelux Corp’s Promising Oncolytic Virus Advancements and Market Potential Drive Buy Rating - TipRanks
Volume spikes in Genelux Corporation stock – what they meanDip Buying & Stepwise Trade Execution Plans - newser.com
Genelux reports Q3 EPS (21c), consensus (21c) - MSN
Promising Clinical Developments in Genelux Corp.’s Olvi-Vec Trials Support Buy Rating - TipRanks
Genelux (GNLX) Projected to Post Earnings on Thursday - Defense World
Will Genelux Corporation stock see insider buyingJuly 2025 Chart Watch & High Accuracy Trade Alerts - Fundação Cultural do Pará
Genelux Corporation Provides Q3 2025 Business and Financial Updates, Anticipates Key Clinical Data Next Year - Quiver Quantitative
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - Stock Titan
[10-Q] GENELUX Corp Quarterly Earnings Report | GNLX SEC FilingForm 10-Q - Stock Titan
Genelux initiated with a Buy at Lake Street - MSN
Will earnings trigger a reversal in Genelux CorporationChart Signals & High Win Rate Trade Tips - newser.com
Genelux commits to lung cancer fight with Olvi-Vec immunotherapy - Traders Union
What MACD and RSI say about Genelux Corporation2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Genelux (NASDAQ:GNLX) Trading Up 3.4%Still a Buy? - MarketBeat
Is Genelux Corporation stock trading near support levelsJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Genelux Corporation (GNLX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Will Genelux Corporation stock keep outperforming rivalsTrend Reversal & Free Reliable Trade Execution Plans - newser.com
How buybacks impact Genelux Corporation stock value2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
Genelux Corp Azioni (GNLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):